A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients

Affiliations

¹ Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; Haemostaseology and Hemophilia Center, Medical Clinic 2, Institute of Transfusion Medicine, University Hospital Frankfurt, Frankfurt, Germany.
² Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; Haemostaseology and Hemophilia Center, Medical Clinic 2, Institute of Transfusion Medicine, University Hospital Frankfurt, Frankfurt, Germany. Electronic address: wolfgang.miesbach@kgu.de.

Comment

E H Adam et al. Thromb Res. 2020 Oct.

. 2020 Oct:194:42-44.

doi: 10.1016/j.thromres.2020.06.026. Epub 2020 Jun 18.

¹ Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; Haemostaseology and Hemophilia Center, Medical Clinic 2, Institute of Transfusion Medicine, University Hospital Frankfurt, Frankfurt, Germany.
² Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany; Haemostaseology and Hemophilia Center, Medical Clinic 2, Institute of Transfusion Medicine, University Hospital Frankfurt, Frankfurt, Germany. Electronic address: wolfgang.miesbach@kgu.de.

No abstract available

Conflict of interest statement

Declaration of competing interest There are no conflicts of interests.

Management of Critically Ill Adults With COVID-19.
Poston JT, Patel BK, Davis AM. Poston JT, et al. JAMA. 2020 May 12;323(18):1839-1841. doi: 10.1001/jama.2020.4914. JAMA. 2020. PMID: 32215647 No abstract available.

1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/s0140-6736(20)30211-7. - DOI - PMC - PubMed
1. Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of Thrombosis and Haemostasis. 2020;18(5):1094–1099. - PMC - PubMed
1. Guan W.-j., Ni Z.-y., Hu Y., Liang W.-h., Ou C.-q., He J.-x., Liu L., Shan H., Lei C.-l., Hui D.S. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020;382(18):1708–1720. - PMC - PubMed
1. Xu J., Wang L., Zhao L., Li F., Liu J., Zhang L., Li Q., Gu J., Liang S., Zhao Q. 2020. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients. - PMC - PubMed
1. Chen J., Wang X., Zhang S., Liu B., Wu X., Wang Y., Wang X., Yang M., Sun J., Xie Y. 2020. Findings of acute pulmonary embolism in COVID-19 patients. (Available at SSRN 3548771)